Itovebi-Based Treatment Has OS Benefit in PIK3CA+ HR+/HER2– Breast Cancer
A Phase 1 Trial of Iadademstat Plus Vidaza Has Dosed a Patient With MDS
Opdivo Plus Yervoy Improves Outcomes in Metastatic Colorectal Cancer Subset
Ovarian Cancer Teaches Hard Life Lessons